Ingalls & Snyder LLC Corcept Therapeutics Inc Transaction History

Ingalls & Snyder LLC

$2.26 Billion
Q1 2024

A detailed history of Ingalls & Snyder LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Ingalls & Snyder LLC holds 1,500 shares of CORT stock, worth $45,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,500

Previous 8,351,827 99.98%

Holding current value

$45,255

Previous $271 Million 99.99%

% of portfolio

0.0%

Previous 12.26%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$21.1 - $27.46 $1.03 Million - $1.34 Million	-48,680 Reduced 0.58%	8,303,147 $209 Million
Q4 2023 Jan 29, 2024	BUY	$24.82 - $32.88 $288,755 - $382,525	11,634 Added 0.14%	8,351,827 $271 Million
Q3 2023 Nov 02, 2023	SELL	$21.97 - $33.8 $445,815 - $685,869	-20,292 Reduced 0.24%	8,340,193 $227 Million
Q2 2023 Jul 27, 2023	SELL	$21.44 - $25.15 $204,366 - $239,729	-9,532 Reduced 0.11%	8,360,485 $186 Million
Q1 2023 May 09, 2023	BUY	$19.2 - $24.47 $29.7 Million - $37.8 Million	1,544,755 Added 22.63%	8,370,017 $181 Million

Q4 2022 Jan 31, 2023	SELL	$19.95 - $29.96 $2.51 Million - $3.77 Million	-125,815 Reduced 1.81%	6,825,262 $139 Million
Q3 2022 Oct 21, 2022	SELL	$24.7 - $29.12 $1.02 Million - $1.2 Million	-41,171 Reduced 0.59%	6,951,077 $178 Million
Q2 2022 Aug 11, 2022	BUY	$17.33 - $25.3 $1.4 Million - $2.05 Million	80,872 Added 1.17%	6,992,248 $166 Million
Q1 2022 May 09, 2022	BUY	$16.53 - $25.21 $2.87 Million - $4.37 Million	173,478 Added 2.57%	6,911,376 $156 Million
Q4 2021 Feb 11, 2022	SELL	$17.1 - $23.34 $5.39 Million - $7.36 Million	-315,472 Reduced 4.47%	6,737,898 $133 Million
Q3 2021 Oct 27, 2021	SELL	$19.68 - $22.53 $350,008 - $400,696	-17,785 Reduced 0.25%	7,053,370 $139 Million
Q2 2021 Aug 03, 2021	BUY	$19.97 - $24.43 $2.48 Million - $3.04 Million	124,423 Added 1.79%	7,071,155 $156 Million
Q1 2021 Apr 21, 2021	SELL	$23.49 - $30.56 $8.35 Million - $10.9 Million	-355,586 Reduced 4.87%	6,946,732 $165 Million
Q4 2020 Jan 27, 2021	SELL	$16.78 - $27.3 $3.18 Million - $5.17 Million	-189,435 Reduced 2.53%	7,302,318 $191 Million
Q3 2020 Oct 21, 2020	SELL	$12.46 - $19.98 $1.34 Million - $2.15 Million	-107,536 Reduced 1.42%	7,491,753 $130 Million
Q2 2020 Jul 31, 2020	SELL	$11.0 - $18.26 $4.45 Million - $7.38 Million	-404,434 Reduced 5.05%	7,599,289 $128 Million
Q1 2020 Apr 22, 2020	SELL	$10.11 - $14.04 $107,449 - $149,217	-10,628 Reduced 0.13%	8,003,723 $95.2 Million
Q4 2019 Jan 15, 2020	SELL	$12.06 - $16.96 $8.42 Million - $11.8 Million	-697,825 Reduced 8.01%	8,014,351 $97 Million
Q3 2019 Oct 16, 2019	BUY	$10.41 - $14.66 $1.98 Million - $2.79 Million	190,377 Added 2.23%	8,712,176 $123 Million
Q2 2019 Jul 11, 2019	BUY	$9.78 - $12.76 $1.47 Million - $1.91 Million	149,798 Added 1.79%	8,521,799 $95 Million
Q1 2019 Apr 11, 2019	SELL	$10.03 - $15.71 $18,936 - $29,660	-1,888 Reduced 0.02%	8,372,001 $98.3 Million
Q4 2018 Jan 24, 2019	SELL	$11.29 - $17.19 $275,148 - $418,937	-24,371 Reduced 0.29%	8,373,889 $112 Million
Q3 2018 Oct 24, 2018	BUY	$12.27 - $15.65 $13.3 Million - $16.9 Million	1,081,270 Added 14.78%	8,398,260 $118 Million
Q2 2018 Aug 10, 2018	BUY	$15.3 - $19.69 $7.64 Million - $9.83 Million	499,450 Added 7.33%	7,316,990 $115 Million
Q1 2018 Apr 17, 2018	SELL	$14.59 - $25.5 $1.55 Million - $2.71 Million	-106,155 Reduced 1.53%	6,817,540 $112 Million
Q4 2017 Jan 19, 2018	BUY	$15.77 - $20.72 $703,294 - $924,049	44,597 Added 0.65%	6,923,695 $125 Million
Q3 2017 Oct 20, 2017	BUY	$12.3 - $19.3 $84.6 Million - $133 Million	6,879,098	6,879,098 $133 Million

Others Institutions Holding CORT

# of Institutions

314

Shares Held

93.8M

Call Options Held

2.02M

Put Options Held

3.24M

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $3.23B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ingalls & Snyder LLC with notifications on news.

Account

Ingalls & Snyder LLC Corcept Therapeutics Inc Transaction History